OVERLAND PARK, Kan.--(BUSINESS WIRE)--Vince & Associates Clinical Research, a premier provider of early phase clinical research services, has been awarded six CRO Leadership Awards in the following categories: Quality, Productivity, Regulatory and Innovation in three sectors – Emerging Pharma, Biotech and Emerging Biotech.
“I am truly honored by the number of awards Vince & Associates has won. More importantly, this recognition is a true testament to the hard work, experience and commitment that our dedicated employees put forth each and every day. The awareness of our pharma and biotech clients of our quality and excellence in the CRO industry is what motivates us to continue to set a new standard in early development clinical trials,” says Dr. Brad Vince, CEO, Medical Director and Founder of Vince & Associates Clinical Research.
The CRO Leadership awards were developed by Life Science Leader magazine to assist life science executives and directors in their vetting process of CROs. The surveys and industry research for this award is managed by Nice Insight, the market research division of That’s Nice LLC. Nice Insight conducts an annual survey on pharmaceutical outsourcing practices to collect baseline customer awareness and customer perception of 100+ CMOs and 70+ CROs. The annual survey includes 250+ questions and is heavily logic based so that the right respondents are asked the right questions. This year over 2,300 pharmaceutical and biopharmaceutical professionals participated in the survey.
About Vince & Associates Clinical Research
Vince & Associates Clinical Research has provided clinical research services to the biopharmaceutical industry for nearly 15 years. The research professionals at Vince & Associates are proud to be recognized in the industry as a “Center of Research Excellence.”
Vince & Associates currently operates a state-of-the-art, multimillion-dollar, 100-bed clinical pharmacology unit that combines the ultimate in subject safety and luxury. This early development unit has the upscale atmosphere necessary for the recruitment and retention of study volunteers in both short- and long-term clinical trials. From the safety and security of the controlled access unit to the added features of a movie theater and game rooms, no detail has been overlooked.
Altasciences is the parent company of wholly owned subsidiaries Vince & Associates Clinical Research (Kansas, USA) and Algorithme Pharma (Quebec, Canada). Both organizations provide comprehensive early stage clinical services in Phase I/IIa, including the necessary support services in this critical stage of drug development.
Additional background materials pertaining to Vince & Associates Clinical Research are located on the corporate website at www.vinceandassociates.com.